RTX outpaces S&P 500 as earnings growth meets valuation questions

RTX’s stronger third-quarter earnings and increased annual outlook have sharpened the debate over whether its shares offer further upside after outperforming the broader market. StockStory’s October 28 assessment put the stock at $195.17, up 11.1% over six months against a 7.5% gain for the S&P 500.

The aerospace and defense company reported third-quarter 2026 sales of $25 billion, an increase of 11% from a year earlier. Adjusted earnings per share rose 33% to $2.26, although that figure included a 25-cent contribution from International Emergency Economic Powers Act cost recovery, according to RTX’s October 20 release.

Management also raised its full-year expectations, projecting adjusted sales of $97 billion to $97.5 billion and adjusted earnings of $7.65 to $7.75 per share. Those forecasts strengthen the operating case for the stock, but they remain management estimates rather than assured results.

StockStory identified underlying revenue growth as one of RTX’s strengths, calculating average annual organic growth of 11% over the past two years. Organic growth helps distinguish expansion within existing operations from changes caused by acquisitions, divestitures and currency movements, making it a useful check on headline sales performance.

Cash generation provided another positive in that assessment. StockStory put RTX’s trailing 12-month free cash flow margin at 9.9%, an improvement of 4.9 percentage points over five years. A higher margin indicates that more revenue remains as cash after operating needs and capital spending, although the longer-term trend does not mean every quarter improves.

Indeed, RTX reported third-quarter free cash flow of approximately $2.1 billion, down 47% from a year earlier, despite its earnings growth. The contrast makes cash conversion an important counterweight to the headline profit figures and illustrates why a single measure cannot settle the investment case.

The principal reservation in StockStory’s analysis concerned capital efficiency. It calculated RTX’s five-year average return on invested capital at 5.3%, suggesting that historical profit generation relative to invested funding was less compelling than recent sales momentum. Improving growth and improving investment returns are related objectives, but they are not interchangeable.

Valuation adds another consideration after the share-price advance. StockStory estimated that RTX traded at 25.4 times forward earnings at the quoted price. That multiple makes delivery against earnings expectations important: stronger operations can support a stock without necessarily establishing that its purchase price offers an attractive margin for disappointment.

The available evidence therefore presents a balance of expanding operations, better longer-term cash margins and questions about capital productivity and price. StockStory’s public article did not issue an explicit buy, sell or hold recommendation, instead directing readers to its fuller research. Its findings should not be treated as a definitive rating.

The next test is whether RTX converts its operating momentum into the results embedded in its upgraded outlook. Management projects full-year free cash flow of $9 billion to $9.2 billion. Delivery against that target, alongside earnings performance and capital efficiency, will help determine whether the recent share-price gains are supported by sustained financial progress.